Jørgen Bjerggaard Jensen
Clinical trials sponsored by Jørgen Bjerggaard Jensen, explained in plain language.
-
Can a short chemo blast before surgery keep bladder cancer away longer?
Disease control CompletedThis study tested whether giving a short, intensive course of chemotherapy (Mitomycin C) directly into the bladder before surgery could reduce the chance of cancer coming back, compared to the usual approach of surgery followed by regular chemotherapy treatments. It involved 120 …
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Urine test could spot bladder cancer sooner in remote areas
Diagnosis CompletedThis study tested whether a simple urine test can help decide who needs a camera exam (cystoscopy) to check for bladder cancer. Researchers studied 127 adults in Greenland, where access to urology services is limited. The goal was to see if the urine test could accurately detect …
Sponsor: Jørgen Bjerggaard Jensen • Aim: Diagnosis
Last updated May 22, 2026 14:03 UTC
-
New bladder cancer surgery could cut recurrence risk
Symptom relief CompletedThis study tested a new surgical technique called En Bloc resection for non-muscle invasive bladder cancer. Instead of removing the tumor in pieces like standard surgery, En Bloc removes it whole. The goal was to see if this method improves tumor removal quality and reduces the c…
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
New scan may spare bladder cancer patients from surgery
Knowledge-focused CompletedThis study tested whether a special type of PET/MR scan can accurately detect if bladder cancer has been completely eliminated by chemotherapy. 13 adults with muscle-invasive bladder cancer were scanned after chemotherapy, and the results were compared to tissue removed during su…
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC